Corporate financial updates: Insider sales and quarterly earnings reports

Various technology and biotechnology companies reported significant financial movements and insider transactions.

Rubrik, Inc. CTO Arvind Nithrakashyap sold 38,460 shares worth approximately $3.0 million under a Rule 10b5-1 trading plan. Despite the sale, he maintains a direct position of 293,293 shares. Arcutis Biotherapeutics saw insider Patrick Burnett sell several batches of shares in August, including a transaction of 6,700 shares at an average price of $26.08.

In terms of growth and earnings, Rigetti Computing reported a 185% year-over-year increase in Q2 2026 revenue, reaching $5.14 million, driven by its quantum processing units. Credo Technology Group saw its share price rise by 8.3% during mid-day trading.

Conversely, several firms experienced stock declines. Red Violet, Inc. fell 5%, and GRAIL, Inc. dropped 6.3%. Silence Therapeutics PLC also saw a 6.9% decline in share price following a quarterly earnings report that missed analyst estimates.